Drug Type Gene therapy |
Synonyms NHR 01, NHR01 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Forge Biologics, Inc.Startup |
Active Organization Forge Biologics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gangliosidoses, GM2 | Phase 2 | US | Forge Biologics, Inc.Startup | 28 Jun 2023 |